Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0068 | 0.1693 | 1 |
Plasmodium falciparum | glutathione reductase | 0.0095 | 0.2653 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0068 | 0.1693 | 0.623 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0095 | 0.2672 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0045 | 0.0907 | 0.3421 |
Toxoplasma gondii | thioredoxin reductase | 0.0095 | 0.2653 | 1 |
Brugia malayi | hypothetical protein | 0.004 | 0.072 | 0.2256 |
Brugia malayi | glutathione reductase | 0.0095 | 0.2653 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0033 | 0.0465 | 0.5 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0033 | 0.0465 | 0.5 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0095 | 0.2653 | 0.2985 |
Brugia malayi | Bromodomain containing protein | 0.0083 | 0.2255 | 0.8406 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.072 | 0.5 |
Leishmania major | trypanothione reductase | 0.0095 | 0.2653 | 1 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0216 | 0.6941 | 0.8837 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0066 | 0.1653 | 0.6076 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.024 | 0.7793 | 1 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0033 | 0.0465 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0023 | 0.0117 | 0.0042 |
Loa Loa (eye worm) | hypothetical protein | 0.0079 | 0.2087 | 0.7866 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0068 | 0.1693 | 0.5614 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.024 | 0.7793 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.004 | 0.072 | 0.065 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.024 | 0.7793 | 1 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0216 | 0.6941 | 0.8837 |
Plasmodium falciparum | thioredoxin reductase | 0.0095 | 0.2653 | 1 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0066 | 0.1653 | 0.6076 |
Brugia malayi | Bromodomain containing protein | 0.0043 | 0.0811 | 0.2622 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0033 | 0.0465 | 0.1234 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0033 | 0.0465 | 0.5 |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0068 | 0.1693 | 0.5614 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.0814 | 0.307 |
Loa Loa (eye worm) | glutathione reductase | 0.0095 | 0.2653 | 1 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0216 | 0.6941 | 0.8837 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0033 | 0.0465 | 0.1502 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.072 | 0.5 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.004 | 0.0718 | 0.2477 |
Plasmodium vivax | glutathione reductase, putative | 0.0095 | 0.2653 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0095 | 0.2653 | 1 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.072 | 0.5 |
Schistosoma mansoni | bromodomain containing protein | 0.007 | 0.1794 | 0.1732 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0033 | 0.0465 | 0.5 |
Mycobacterium tuberculosis | Probable reductase | 0.0216 | 0.6941 | 0.8837 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.0982 | 0.3704 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.004 | 0.072 | 0.2483 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0068 | 0.1693 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0095 | 0.2653 | 1 |
Mycobacterium tuberculosis | Probable aldehyde dehydrogenase | 0.0068 | 0.1693 | 0.1676 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0033 | 0.0465 | 0.0393 |
Schistosoma mansoni | hypothetical protein | 0.004 | 0.072 | 0.065 |
Trypanosoma brucei | trypanothione reductase | 0.0095 | 0.2653 | 1 |
Mycobacterium ulcerans | aldehyde dehydrogenase | 0.0068 | 0.1693 | 1 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0023 | 0.0117 | 0.044 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0068 | 0.1693 | 0.623 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0216 | 0.6941 | 0.8837 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0033 | 0.0465 | 0.1502 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.024 | 0.7793 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0095 | 0.2672 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.004 | 0.072 | 0.2483 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0095 | 0.2653 | 1 |
Echinococcus multilocularis | fetal alzheimer antigen, falz | 0.0025 | 0.0192 | 0.0449 |
Echinococcus granulosus | fetal alzheimer antigen falz | 0.0025 | 0.0192 | 0.0449 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.004 | 0.0718 | 0.2477 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0216 | 0.6941 | 0.8837 |
Treponema pallidum | NADH oxidase | 0.0033 | 0.0465 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0033 | 0.0465 | 0.5 |
Brugia malayi | PHD-finger family protein | 0.0028 | 0.0285 | 0.0512 |
Entamoeba histolytica | hypothetical protein | 0.004 | 0.072 | 0.5 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0068 | 0.1693 | 0.163 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0025 | 0.0192 | 0.0118 |
Brugia malayi | Thioredoxin reductase | 0.0095 | 0.2653 | 1 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0068 | 0.1693 | 0.163 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 292 uM | Concentration of the compound that produced 50% reversal of pancuronium induced neuromuscular block in the chick biventer assay | ChEMBL. | 11858995 |
EC50 (functional) | = 563 uM | Concentration of the compound that produced 50% reversal of gallamine induced neuromuscular block in the chick biventer assay | ChEMBL. | 11858995 |
Ka (functional) | = 2500 M-1 | Tested for association constant against pancuronium relaxant in chick biventer muscle preparation | ChEMBL. | 11858995 |
Ka (functional) | = 3275 M-1 | Tested for association constant against gallamine relaxant in chick biventer muscle preparation | ChEMBL. | 11858995 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.